The intellectual property literature concerning novel anti-Helicobacter age
nts for the period of 1998 and 1999 is served. The majority of the citation
s described herein involve the synthesis and evaluation of new compounds an
d the identification of new vaccine candidate antigens and their formulatio
n. Despite the large number of novel anti-H. pylori agents under developmen
t, no significant advances have been made in H. pylori therapy or vaccinati
on in this period.